Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

On September 15, 2021, the U.S. Food and Drug Administration (FDA) granted accelerated approval to zanubrutinib for the treatment of adult patients with relapsed...

Mantle cell lymphoma (MCL) is a B-cell lymphoma with marked heterogeneity in clinical presentation, molecular profile, and managementβ€”in both the frontline and relapsed/refractory (R/R)...

During the Society of Hematologic Oncology (SOHO) 2021 Annual Meeting, the Lymphoma Hub was pleased to speak to Alexey Danilov, City of Hope Comprehensive...

Online lymphoma resource for healthcare professionals, providing information, news & support relating to lymphoma, Hodgkin & non Hodgkin...

The main results from the ELEVATE TN trial (NCT02475681) in patients with untreated chronic lymphocytic leukemia (CLL) were first presented by Jeff P. Sharman...

For patients with early-stage Hodgkin lymphoma (ES-HL), the decision to assign either radiotherapy or no further treatment following chemotherapy requires balancing the risk of...

During the 2021 ASCO Annual Meeting, the Lymphoma Hub spoke with Frederick Locke, Moffitt Cancer Center, Tampa, US. We asked, Is ALLO-501A a promising...

Mashup Score:1

lymphomahub.com

Home | Lymphoma Hub - 2 weeks

Mashup Score:1

Online lymphoma resource for healthcare professionals, providing information, news & support relating to lymphoma, Hodgkin & non Hodgkin...